Placeholder Banner

BIO Comments on FDA voluntary labeling of GE salmon

January 26, 2016
Dear Sir/Madam:
 
The Biotechnology Innovation Organization (BIO) appreciates the opportunity to provide input on the U.S. Food and Drug Administration’s (FDA) draft guidance for industry on voluntary labeling of food derived from genetically engineered and non-genetically engineered Atlantic salmon (Salmo salar). BIO is the world's largest biotechnology trade association, representing companies, academic institutions, state biotechnology centers and related organizations. BIO members use biotechnology at all stages of research and product development to further innovation in a variety of economic sectors including human health, agricultural production, food processing, industrial manufacturing, energy production and environmental management.
 
The tools of biotechnology, which include genetic engineering, are used by many BIO members to develop and produce a wide variety of food and feed products, additives, processing aids and related detection technologies. As a result, BIO has a strong interest in FDA’s consistently applying the appropriate laws, regulations, and scientific principles to its requirements for food labels and labeling.
Download Full Comments Below
BIO Comments FDA Voluntary Label GE Salmon
Read full comments here: BIO Comments on FDA voluntary labeling of GE salmon
Discover More
The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments regarding the request and comments on the Advanced Manufacturing Technologies Designation Program Draft Guidance.
The Biotechnology Innovation Organization thanks the Food and Drug Administration for the opportunity to submit comments regarding the request for information and comments on the Food and Drug Administration's Draft Report and Plan on Best Practices…
Following the FDA Workshop to Enhance Clinical Study Diversity on November 29-30, 2023, BIO submits specific comments per the request for information (FDA-2023-N-2462).